Flexible Screen Maker Relocating Its Headquarters in Norcross, GA, and Adding 175 Jobs
10/24/2011
Founded in 2006, NanoLumens designs and manufactures unique flexible displays that address a major technology gap in the $14 billion digital display industry. Its ultra-lightweight, thin and energy-efficient digital displays can be wrapped around curved walls and columns, and mounted to fit any surface. They are well-suited for the indoor advertising venues in subways, airports, shopping malls, stadiums, hotels, etc.
"Our company has more than doubled in size over the last two years and we expect 2012, our first full year of commercial production, to create an even faster rate of growth," said CEO Rick Cope. "This new headquarters will enable us to comfortably grow and meet our customer demands..[and] house the largest digital display showroom in the country."
NanoLumens has many customers in the United States and Canada, and Cope said it is now expanding in Europe, the Middle East and South America where demand is for high for his firm's innovative products.
Project Announcements
Electric Research and Manufacturing Cooperative Plans Waddell, Arizona, Transformer Production Operations
01/23/2026
Viking Attachments Expands Morgan City, Louisiana, Manufacturing Operations
01/23/2026
France-Based Reju Plans Rochester, New York, Textile Regeneration Operations
01/23/2026
Heil Trailer International Expands Athens, Tennessee, Manufacturing Operations
01/23/2026
Ampirical Expands Covington, Louisiana, Operations
01/23/2026
Laser Isotope Separation Technologies Plans Oak Ridge, Tennessee, Uranium Enrichment Operations
01/22/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025